Found: 25
Select item for more details and to access through your institution.
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0138341
- By:
- Publication type:
- Article
Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00331-8
- By:
- Publication type:
- Article
Correction to: Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.
- Published in:
- EJNMMI Physics, 2020, v. 7, n. 1, p. 1, doi. 10.1186/s40658-020-00345-4
- By:
- Publication type:
- Article
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18 F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2752, doi. 10.3390/cancers12102752
- By:
- Publication type:
- Article
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 10, p. 1792, doi. 10.1007/s00259-016-3365-x
- By:
- Publication type:
- Article
Tumour targeting and radiation dose of radioimmunotherapy with Y-rituximab in CD20+ B-cell lymphoma as predicted by Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 8, p. 1304, doi. 10.1007/s00259-015-3025-6
- By:
- Publication type:
- Article
Accuracy and precision assessment for activity quantification in individualized dosimetry of Lu-DOTATATE therapy.
- Published in:
- EJNMMI Physics, 2017, v. 4, n. 1, p. 1, doi. 10.1186/s40658-017-0174-7
- By:
- Publication type:
- Article
<sup>90</sup>Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0419-z
- By:
- Publication type:
- Article
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 326, doi. 10.1016/j.clcc.2021.07.006
- By:
- Publication type:
- Article
Optimal [<sup>18</sup>F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266384
- By:
- Publication type:
- Article
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.245357
- By:
- Publication type:
- Article
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.245357
- By:
- Publication type:
- Article
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.245357
- By:
- Publication type:
- Article
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.245357
- By:
- Publication type:
- Article
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.245357
- By:
- Publication type:
- Article
Combining <sup>18</sup>F-FDG PET/CT-based Metabolically Active Tumor Volume and Circulating Cell-free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.222919
- By:
- Publication type:
- Article
Combining <sup>18</sup>F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 10, p. 1366, doi. 10.2967/jnumed.118.222919
- By:
- Publication type:
- Article
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as <sup>18</sup>F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 2, p. 178, doi. 10.2967/jnumed.118.210161
- By:
- Publication type:
- Article
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 7, p. 712, doi. 10.3390/diagnostics14070712
- By:
- Publication type:
- Article
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-023-00610-6
- By:
- Publication type:
- Article
Clinicopathological and molecular predictors of [<sup>18</sup>F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 9, p. 2733, doi. 10.1007/s00259-024-06683-0
- By:
- Publication type:
- Article
Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 11, p. 2270, doi. 10.1007/s00259-019-04427-z
- By:
- Publication type:
- Article